RPE-P/TLIF for Lumbar Spinal Stenosis With Instability

NCT06290908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2024-03-04

No results posted yet for this study

Summary

Objective To analyze the effectiveness and safety of robot-assisted percutaneous endoscopic posterior/transforaminal lumbar interbody fusion (RPE-P/TLIF) in the treatment of lumbar spinal stenosis with instability. Methods A single-center prospective study from September 2018 to April 2022, patients with lumbar spinal stenosis and instability who met the inclusion and exclusion criteria were treated with RPE-P/TLIF. Pain visual analog scale (VAS) was used to evaluate the degree of low back pain and lower limb pain before operation, 1 month, 6 months, 1 year after operation and at the final follow-up, and the Oswestry disability index (ODI) was used to evaluate the degree of lumbar spinal function. At the last follow-up, MacNab criteria were used to evaluate the clinical efficacy. Imaging evaluation included the measurement of intervertebral space height, lumbar physiological curvature, fusion rate and pedicle screw accuracy by preoperative and lateral X-ray films.

Conditions

  • Spinal Stenosis

Interventions

PROCEDURE

RPE-P/TLIF

patients with lumbar spinal stenosis and instability who met the inclusion and exclusion criteria were treated with RPE-P/TLIF

Sponsors & Collaborators

  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Wen-xi Sun

    lead OTHER

Principal Investigators

  • Yong-peng Lin, dr · Guangdong Provincial Hospital of Traditional Chinese Medicine

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-04
Primary Completion
2022-04-30
Completion
2024-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06290908 on ClinicalTrials.gov